You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

insulin degludec/insulin aspart

Showing 1 - 25 of 8,128
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes Trial (Insulin Degludec and Insulin Aspart)

Not yet recruiting
  • Diabetes
  • Insulin Degludec and Insulin Aspart
  • (no location specified)
Apr 4, 2023

Type 2 Diabetes Trial in China (Insulin Degludec and Insulin Aspart Injection, Insulin Aspart Injection)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • Insulin Degludec and Insulin Aspart Injection
  • Insulin Aspart Injection
  • Shijiazhuang, Hebei, China
  • +5 more
Jun 13, 2022

Type 1 Diabetes With Diabetic Gastroparesis, HbA1c, Time in Range Trial in Hangzhou (insulin degludec/insulin aspart (IDegAsp),

Recruiting
  • Type 1 Diabetes Mellitus With Diabetic Gastroparesis
  • +2 more
  • insulin degludec/insulin aspart (IDegAsp)
  • basal insulin plus pre-prandial insulin
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jul 7, 2021

Ryzodeg® in Adult Patients With Type 2 Diabetes in Lebanon

Enrolling by invitation
  • Diabetes Mellitus, Type 2
  • Insulin Degludec/Insulin Aspart
  • Beirut, Hamra, Beirut, Lebanon
    Novo Nordisk Investigational Site
Sep 30, 2021

Diabetes, Type 2 Treated With Insulin Trial in Bogotá (insulin degludec + liraglutide, Insulin Glargine - Insulin Aspart)

Recruiting
  • Diabetes Mellitus, Type 2 Treated With Insulin
  • insulin degludec + liraglutide
  • Insulin Glargine - Insulin Aspart
  • Bogotá, Colombia
    Hospital Universitario San Ignacio
Mar 2, 2023

Liver Cirrhosis, Diabetes Trial in Shanghai (Insulin Degludec and Insulin Aspart)

Recruiting
  • Liver Cirrhosis
  • Diabetes
  • Insulin Degludec and Insulin Aspart
  • Shanghai, Shanghai, China
    Xiaolong Zhao
Nov 29, 2022

Ryzodeg® inReal-world Adult Population With Type 2 Diabetes in

Completed
  • Diabetes Mellitus, Type 2
  • Daejeon, Korea, Republic of
  • +5 more
Sep 27, 2021

Diabetes, Type 1, Diabetes, Type 2 Trial in China (Faster aspart, Insulin aspart, Insulin degludec)

Completed
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2
  • Faster aspart
  • +2 more
  • Hefei, Anhui, China
  • +34 more
Nov 3, 2022

Type 2 Diabetes Trial in Cleveland (Semaglutide, Insulin Degludec, Insulin aspart)

Recruiting
  • Type 2 Diabetes
  • Cleveland, Ohio
    Cleveland Clinic
Jul 18, 2022

(rPMS) Study of Ryzodeg® FlexTouch® to Evaluate Safety and

Completed
  • Diabetes
  • +2 more
  • Insulin degludec /insulin aspart
  • Busan, Korea, Republic of
  • +26 more
Nov 9, 2021

Type 2 Diabetes Trial in Atlanta, New York, Spokane (Degludec, Glargine, Aspart)

Completed
Has Results
  • Type 2 Diabetes
  • Atlanta, Georgia
  • +3 more
Mar 25, 2022

Type 1 Diabetes Trial in Aurora (Multiple daily ijnection using Insulin Degludec and Insulin Aspart)

Completed
Has Results
  • Type 1 Diabetes
  • Multiple daily ijnection using Insulin Degludec and Insulin Aspart
  • Aurora, Colorado
    Barbara Davis Center for Diabetes
Sep 9, 2021

NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects Blood

Enrolling by invitation
  • Diabetes Mellitus, Type 1
  • Insulin degludec
  • Fast-acting insulin aspart
  • Bonheiden, Belgium
  • +22 more
Dec 19, 2022

Diabetes, Type 1 Trial in Worldwide (insulin icodec, insulin degludec, insulin aspart)

Completed
  • Diabetes Mellitus, Type 1
  • insulin icodec
  • +2 more
  • Concord, California
  • +98 more
Feb 2, 2023

Type1 Diabetes Trial in Asheville (Aspart)

Completed
  • Type1 Diabetes Mellitus
  • Asheville, North Carolina
    Mountain Diabetes and Endocrine Center
Feb 23, 2021

Diabetes, Diabetes, Type 1 Trial in Worldwide (Insulin degludec, Insulin Aspart, Insulin detemir)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 1
  • Insulin degludec
  • +2 more
  • Caba, Argentina
  • +70 more
Mar 29, 2022

Type 1 Diabetes Trial in Málaga (Toujeo SoloStar, Tresiba, Humalog Kwikpen)

Completed
  • Type 1 Diabetes Mellitus
  • Toujeo SoloStar
  • +4 more
  • Málaga, Spain
    Regional University Hospital of Málaga
Nov 23, 2021

Looking at How Ryzodeg® Works in People With Type 2 Diabetes in

Recruiting
  • Diabetes Mellitus, Type 2
  • Hefei, Anhui, China
  • +50 more
Feb 2, 2023

Diabetes, Type 1 Trial (Afrezza, insulin degludec, Rapid-acting Insulin Analog)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Afrezza
  • +3 more
  • (no location specified)
Jun 6, 2023

Diabetes, Critical Illness, Hyperglycemia Trial in Riyadh (Degludec insulin)

Recruiting
  • Diabetes Mellitus
  • +2 more
  • Degludec insulin
  • Riyadh, Saudi Arabia
    King Faisal Specialist Hospital & Research Centre
Sep 24, 2023

Healthy Trial in Beijing (insulin degludec/insulin aspart)

Completed
  • Healthy
  • insulin degludec/insulin aspart
  • Beijing, China
    Novo Nordisk Investigational Site
Feb 13, 2020

Type 1 Diabetes Trial in Cambridge (CamAPS FX using faster insulin aspart, CamAPS FX using standard insulin aspart)

Active, not recruiting
  • Type 1 Diabetes Mellitus
  • CamAPS FX using faster insulin aspart
  • CamAPS FX using standard insulin aspart
  • Cambridge, Cambridgeshire, United Kingdom
  • +1 more
Nov 9, 2022

Diabetes, Type 1 Trial in Santa Barbara, Honolulu (Insulin Degludec, Insulin Glargine, TRESIBA® FLEXTOUCH®)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Insulin Degludec
  • +3 more
  • Santa Barbara, California
  • +1 more
Oct 6, 2022

Type 2 Diabetes Trial in Chengdu (Insulin degludec injection, RD15003, Insulin degludec, Tresiba)

Completed
  • Type 2 Diabetes
  • Insulin degludec injection, RD15003
  • Insulin degludec, Tresiba
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Oct 7, 2022

Pharmacokinetics, Pharmacodynamics Trial in Chula Vista (I004, NovoLog)

Recruiting
  • Pharmacokinetics
  • Pharmacodynamics
  • Chula Vista, California
    Amphastar Study Site
Sep 13, 2022